Globus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 23   

Articles published

GMED 15.62 -0.10 (-0.64%)
price chart
Portfolio: Jury says Globus Medical infringed on patents
Audubon-based Globus Medical Inc., a spinal implant manufacturer, announced the jury in a patent infringement case in the U.S.
Globus Medical Rating Reiterated by Canaccord Genuity (GMED)  Mideast Time
Globus Medical Rating Reiterated by Piper Jaffray (GMED)  Zolmax
Related articles »  
Globus Medical Announces Jury Verdict in Patent Infringement Lawsuit
Globus Medical, Inc. is a leading spinal implant manufacturer based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with ...
Globus Medical: An Overlooked Company With A Moat
Globus Medical, Inc. (GMED) is a business Warren Buffett would love. The company is simple to understand, has an economic moat, great management and is selling at a reasonable price.
Globus Medical Inc. (NYSE:GMED) aims to improve the healing in patients with ...
Boston, MA 06/18/2013 (wallstreetpr) - The share prices of Globus Medical Inc. (NYSE:GMED) had surged by 4.54 percent to close at $15.88 per share for the end of last trading session on Monday.
Globus Medical Receives Overweight Rating from Piper Jaffray (GMED)
Globus Medical (NASDAQ: GMED) traded down 0.50% on Monday, hitting $15.7999. Globus Medical has a 1-year low of $10.26 and a 1-year high of $19.93.
GLOBUS MEDICAL INC : Algea Therapies Launches SHIELD VCF System
Algea Therapies, a division of Globus Medical Inc. (NYSE: GMED), committed to finding innovative, minimally invasive solutions that treat pain and restore quality of life, today announced the launch of the SHIELD?
Related articles »  
Globus Medical to Participate at Investor Events in June
Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced that Richard Baron, Senior Vice President and Chief Financial Officer, will participate in upcoming investor events in June: Goldman Sachs 34th Annual Global ...
Related articles »  
Globus Medical Receives New Coverage from Analysts at WallachBeth Capital ...
Globus Medical (NASDAQ: GMED) remained flat at $15.90 during trading on Friday. Globus Medical has a 52-week low of $10.26 and a 52-week high of $19.93.
Small Cap Spinal and Back Pain Stocks to Treat Your Portfolio: ATEC, OFIX ...
Small cap stocks Alphatec Holdings Inc (ATEC), Orthofix International NV (OFIX), Globus Medical Inc (GMED) and BioRestorative Therapies (BRTX) are focused on treating back pain or spinal disorders.
J&J's Depuy Synthes Wins $16 Million in Patent Case
Johnson & Johnson's (JNJ) DePuy Synthes unit, a maker of artificial spinal repair products, won $16 million in damages from Globus Medical Inc. (GMED) when a jury decided that three of its patents were infringed. A federal jury in Wilmington, Delaware ...